companydata.dkPerfusion Tech ApS: Financial statements 2023
CVR: 38238213
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,414,376 and a net result of DKK -9,544,785 compared with DKK -6,556,178 the year before. Equity amounted to DKK 2,873,118. The solvency ratio was 32.5%. The company had 8 employees in the financial year.
- Gross Profit
- -5,414,376 kr.
- Profit/Loss
- -9,544,785 kr.
- Equity
- 2,873,118 kr.
- Total Assets
- 8,832,353 kr.
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5.4 mio. | -9.5 mio. | 2.9 mio. | 8 |
| 2022 | - | -4.2 mio. | -6.6 mio. | 1.2 mio. | 7 |
| 2021 | - | -1.1 mio. | -2.1 mio. | -3.9 mio. | 4 |
| 2020 | - | -1.1 mio. | -1.5 mio. | -1.8 mio. | 3 |
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 1, 2023, Pernille Charlotte Singer is registered as adm. dir. of Perfusion Tech ApS.
As of October 1, 2023, Mads Aagaard Linde Madsen has stepped down as adm. dir. of Perfusion Tech ApS.
As of September 30, 2023, Pernille Charlotte Singer has stepped down as director of Perfusion Tech ApS.
As of September 22, 2023, Henrik Christensen has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Morten Asp Vonsild Lund has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Declan Cassells has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Lars Henning Stigel has left the board of directors of Perfusion Tech ApS.
As of September 21, 2023, Henrik Christensen has left the board of directors of Perfusion Tech ApS.
As of September 21, 2023, Morten Asp Vonsild Lund has left the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2022. Gross profit came to DKK -4,201,186, and the net result was DKK -6,556,178.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity amounted to DKK -9,640,655.